ALGBE — Global Bioenergies SA Income Statement
0.000.00%
Last trade - 00:00
- €28.34m
- €24.36m
- €3.25m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.117 | 0.064 | 0.101 | 0.698 | 3.25 |
Cost of Revenue | |||||
Gross Profit | -8.49 | -8.66 | -10 | -7.97 | -4.98 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14 | 13.3 | 13.5 | 14 | 13.2 |
Operating Profit | -13.9 | -13.2 | -13.3 | -13.3 | -9.95 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.1 | -13.4 | -13.5 | -13.4 | -9.84 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.7 | -11.1 | -11.8 | -12 | -8.66 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.7 | -11.1 | -11.8 | -12 | -8.66 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.7 | -11.1 | -11.8 | -12 | -8.66 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.45 | -1.1 | -0.78 | -0.781 | -0.45 |
Dividends per Share |